LS@W alumnus Khondrion published the results of their phase 2 KHENERGY study on safety and efficacy of KH176 in patients with mitochondrial disease
KHENERGY study provides first data on safety and efficacy of KH176 in patients with mitochondrial disease Results…
Recent Comments